BGLAP and Alzheimer disease: Experimental evidence suggests osteocalcin enhances neuronal viability and synaptic adaptability, whereas diminished bone mineral density may correlate with AD progression[2].Age-related degenerative processes associated with global population aging potentially exacerbate cognitive deterioration through impaired skeletal-neural crosstalk mechanisms[50].